This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Gilead Sciences, Inc., Nurix Therapeutics, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 946 
2 out of 22 Years Active: 2024-2026
Title: Kerem Ozboya - Innovator in Pharmaceutical Chemistry
Introduction
Kerem Ozboya is a prominent inventor based in San Francisco, CA, known for his contributions to pharmaceutical chemistry. With a focus on developing innovative compounds, he has made significant strides in the field of drug discovery.
Latest Patents
Ozboya holds a patent for "Substituted pyrrolo[1,2-b]pyridazines as bifunctional degraders of interleukin-1 receptor-associated kinases." This patent presents bifunctional compounds that act as IRAK4 degraders through the ubiquitin proteasome pathway, offering potential methods for treating diseases modulated by IRAK4.
Career Highlights
Currently, Ozboya is associated with Gilead Sciences, Inc., where he applies his expertise in medicinal chemistry to advance therapeutic solutions. His work is characterized by a commitment to innovation and excellence in drug development.
Collaborations
Throughout his career, Ozboya has collaborated with notable colleagues, including Wylie Palmer and Jeffrey Wu, contributing to a dynamic research environment that fosters creativity and scientific advancement.
Conclusion
Kerem Ozboya's innovative work in pharmaceutical chemistry and his dedication to developing new therapeutic agents position him as a key figure in the field, with the potential to impact the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile